MSD's efforts to combine cancer immunotherapy Keytruda with its AstraZeneca-partnered PARP drug Lynparza have so far failed – but at last it can point to a partial win in a phase 3 trial. The new data ...
Armed with positive results in two phase 3 trials, MSD is poised to be the first drugmaker to file for approval of an oral PCSK9 inhibitor for lowering cholesterol. Top-line results from the CORALreef ...
Photoshop cc 2015 tutorial showing how to transform your photos into fun, color-grid, mosaic graphics. Photo provided by Image ID: 333627197 Royalty-Free Music provided by High quality, copyright-free ...
Abstract: Unveiling feeder topologies from data is of paramount importance to advance situational awareness and proper utilization of smart resources in power distribution grids. This tutorial ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Abstract: High penetration of renewable energy resources in the power system results in various new challenges for power system operators. One of the promising solutions to sustain the quality and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results